The Eurosymposium on Healthy Ageing (EHA) is an international event that provides a unique opportunity for researchers, government officials, biotech executives, entrepreneurs, and non-governmental institutions from around the world to meet, network, and forge new scientific collaborations. The EHA is a biannual conference organized for the first time in 2012 by the European non-governmental organization HEALES, a Brussels-based association stimulating, promoting and informing the public about healthy life extension. Driving Heales and the development of the EHA conference are its two co-presidents, Sven Bulterijs and Didier Coeurnelle.
The world has already faced the variety of challenges caused by an ageing population and the so called 'Silver tsunami', but following major discoveries in science and biomedicine in recent years we are now on the edge of a paradigm shift from treatment to prevention and an improvement in healthy longevity. The quickly growing trend has been marked by a number of speakers at the "World Economic Forum" in Davos and echoed by the major media such as The Economist journal which began a series of conferences in 2016 called "Ageing Societies" and "The business of longevity".
The EHA is the largest and the most authoritative conference on the subject of longevity in Northern Europe. It provides a unique platform with the particular purpose to embrace the latest findings made by passionate scientific individuals. The programme board encourages you to immerse yourself into the programme for knowledge exchange and new network creation. The time has come to live longer healthier lives, and everyone is welcome to learn about the latest discoveries in the science of healthy longevity.
This year we have over 30 scientific lectures and 3 panel sessions by the most prominent scientists in the field of biotechnology and regenerative medicine, providing access to the forefront of scientific research in the field of ageing. The keynote lecture on the first day will be given by the renowned tissue engineer Dr. Alexander Seifalian (University College London). On the second day the keynote will be given by one of the leading experts in the biology of aging, Dr. David Gems (University College London). The three days are filled with lectures given by a number of the brightest minds in biomedicine from the University of Cambridge, University of Oxford, University College London, Maastricht University and many other reputable scientific institutions.
Over the recent decades, science has been exploring how to tackle the root and consequences of ageing. While in previous years the field of longevity was explored exclusively by the scientific community, it is now widely studied and represented by the innovative general public. The biotech industry of aging has come to maturation in recent years with the founding of many biotech companies focused on aging, for example Calico, InSilico Medicine, BioViva, Human Longevity inc., and many others. This year the conference will host a number of entrepreneurs and venture investors including Dmitry Kaminskiy, the general partner of Deep Knowledge Ventures.
The conference will last 3 days, during which the participants will cover a wide range of questions from deep research and practical medical applications to investment issues. The first two days will be devoted to discussing the biology of aging and the biotech market. The last day will centre around the societal, ethical and economical aspects of aging. Europe has already faced a variety of challenges caused by the 'silver tsunami' in a manner similar to Japan, both from the economic and sociological points of view. What if the process of getting old could be mitigated and associated diseases prevented? What opportunities are there for the non-scientific community? The conference will raise the critical issues of related finance aspects, public health issues, investments and business opportunities arising out of ageing societies. In collaboration with Deep Knowledge Ventures we will discuss these matters with leading representatives. The conference will end with the adoption of a Declaration for Longevity in which the importance of longevity research will be stated, and tangible steps will be set to achieve this goal.
This year the conference will become multidisciplinary and even more informative and thought-provoking. Due to the subject's rising popularity and the exponentially growing knowledge in the field, the conference will take an annual form starting this year.
Join us in the Royal Library of Belgium at the EHA 2016, the pre-eminent longevity think tank in Northern Europe!
Follow us on Twitter: https:/
Join our LinkedIn group: https:/
Co-president of Heales
32-495-31-49-99 (English - Dutch)
Co-president of Heale
33-489-43-55-94 (English - French)
Sven Bulterijs - is the co-founder of Heales and currently serves as its co-president & CSO. He has studied biochemistry and biotechnology at the University of Ghent (Belgium) and has worked in the lab of David Spiegel at Yale University. He has published multiple peer-reviewed papers and has lectured at multiple international conferences. He is a long-time proponent of healthy life extension, and has been involved in advocacy and outreach for many years.
Didier Coeurnelle, born in 1962, is co-founder and co-president of Heales and a member of the board of the International Longevity Alliance. He is also a lifelong member of Longecity (former Immortality Institute) and a donor to the SENS Foundation. As a member of Heales, Didier publishes the monthly newsletter La mort de la mort (in French). He has also taken part in many conferences and had many TV appearances about longevity. He has also written two books about longevity and technological progress. Didier is a jurist, working in Belgium as a civil servant specialized in Social Security. He is also politically active in social and ecologist movements and defines himself as a social activist and world citizen.
The Healthy Life Extension Society (HEALES) is a Brussels-based non-governmental association stimulating, promoting and informing the public about healthy life extension. In addition Heales supports scientific research into the biology of aging and works together with national and international policy makers. We believe it is time to switch from the current paradigm of treating disease to one of preventative gerontology. By intervening in the mechanisms underlying biological aging we believe it is possible to simultaneously delay or prevent the development of all age-related diseases including Alzheimer's disease, Parkinson's disease, cardiovascular diseases, osteoporosis and many more.
Deep Knowledge Ventures is a new type of investment fund using a novel appropriate investment approach and decision-making process based on the worldwide, advanced scientific expertise and sophisticated data-driven analytical tools empowered by AI. The Fund works on the major global challenges related to demographic ageing and the integration of AI with an exponentially expanding flow of bioinformatic data. The main mission of the fund is to trigger the shift of a global paradigm from treatment to prevention and refocus healthcare systems towards a model of healthy longevity within a 5 year period on a global scale.
Dmitry Kaminskiy is an innovative entrepreneur and investor who is active in the fields of BioTech, FinTech, BlockChain and Artificial Intelligence. Kaminskiy is a co-founder and a senior partner at Deep Knowledge Ventures. Dmitry is a leading visionary in the field of ultra-innovative technologies. In addition to his business experience, Kaminskiy is involved in several scientific endeavors. Dmitry's major interest is anti-aging and healthy longevity which he has engaged in business, research and public activities. Dmitry is well known for his support of life extension think-tanks in UK and many other non-profit activities. Mr Kaminskiy's US$1 million prize for the first person to reach their 123th birthday went viral, and was widely covered by the world's top media.
Biogerontology Research Foundation (BGRF) has been constituted as a charity in the UK to support the application of knowledge of the mechanisms of ageing to the relief of disability, suffering and disease in old age. The BGRF accelerates progress in biotech and regenerative medicine field by encouraging collaboration between researchers and scientists in different fields and organising seminars and conferences.